Sorin secures option-to-buy in mitral valve start-up HighLife with €4.2m minority stake
This article was originally published in Clinica
Executive Summary
Sorin has acquired a minority stake in HighLife SAS, a French, early-stage developer of a transcatheter mitral valve replacement system, for €4.2 million ($5.4 million).